Subtle changes in chemical structure can affect drug toxicity

January 15, 2018, National University of Singapore
Subtle changes in chemical structure can affect drug toxicity
Derivatives of lumiracoxib were synthesised to understand the contribution of different chemical groups to toxicity. The compounds were tested in human liver cells, and also with and without the presence of glutathione (GSH, an anti-oxidant), in human liver microsomes (HLMs). Changes to compound stability (via formation of oxidised products, -OH), chemical reactivity, and metabolite formation were observed and they allude to the mechanism for causing toxicity. Credit: Ho Han Kiat, published in Chemical Research in Toxicology, 2016.

NUS pharmaceutical scientists have discovered the mechanisms involved when small chemical modifications to certain pharmaceutical drugs may cause harm instead of improving treatment.

The process of design to improve therapeutic activities involves making small changes to drug molecules. However, it is a less known fact that the same alterations may worsen drug toxicities as an unintended effect. This means that these drugs, modified to enhance treatment, may instead be undesirable for the patient.

A research team led by Prof HO Han Kiat from the Department of Pharmacy, NUS has discovered the mechanisms involved when minor chemical modifications such as a single substitution of a small halogen or alkyl group (functional groups in chemical structures) of pharmaceutical drugs alters the profile of the drugs. Chemical modifications can cause the drug to have both beneficial and adverse effects on patients. In certain situations, these two effects can be dissociated from each other. By understanding the specific mechanisms contributing to the toxicity, pharmaceutical scientists can modify the chemical structure so as to develop drugs which are more effective and safe.

Using in vitro experiments with human , the team found that minor chemical modifications can affect the stability of drug compounds as these alter the generation of reactive metabolites. Many of the resulting metabolites may disrupt the usual functions of proteins, DNAs and other biological molecules.

Prof Ho Han Kiat with his research team investigating the mechanisms involved when small chemical modifications are made to pharmaceutical drugs. Credit: National University of Singapore

As part of the research, the team used a pair of anti-inflammatory drugs, diclofenac and lumiracoxib, that differ minimally in terms of structure, but exhibit profound differences in terms of toxicity. Diclofenac is a relatively safe painkiller still in wide usage today, while lumiracoxib has been withdrawn from the market due to severe liver toxicity. Many other compounds with small chemical changes were also synthesised and evaluated for their potential to cause toxicity and how they may be metabolised differently in liver cells.

Prof Ho said, "The research findings show that it is important to examine the potential toxicological impact when making minor chemical changes to . It also provides a methodology to guide future work in other compounds."

Explore further: Gut bacteria influences drug-induced liver injury

More information: Yi Yun Pang et al. Phase I Metabolic Stability and Electrophilic Reactivity of 2-Phenylaminophenylacetic Acid Derived Compounds, Chemical Research in Toxicology (2016). DOI: 10.1021/acs.chemrestox.6b00042

Yi Yun Pang et al. Structure–toxicity relationship and structure–activity relationship study of 2-phenylaminophenylacetic acid derived compounds, Food and Chemical Toxicology (2014). DOI: 10.1016/j.fct.2014.06.013

Related Stories

Gut bacteria influences drug-induced liver injury

September 11, 2017

Pharmaceutical drugs are broken down by enzymes in the liver into their metabolites, which are subsequently excreted in the faeces and urine. Drugs can also undergo chemical reactions mediated by bacteria within the gut, ...

Cell-derived drug delivery systems

December 4, 2017

NUS pharmaceutical scientists have developed a cost-effective method to produce cell-derived nanovesicles (CDNs) for bio-inspired drug delivery applications.

Recommended for you

Scientists bring polymers into atomic-scale focus

November 12, 2018

From water bottles and food containers to toys and tubing, many modern materials are made of plastics. And while we produce about 110 million tons per year of synthetic polymers like polyethylene and polypropylene worldwide ...

Synthetic molecule invades double-stranded DNA

November 12, 2018

Carnegie Mellon University researchers have developed a synthetic molecule that can recognize and bind to double-stranded DNA or RNA under normal physiological conditions. The molecule could provide a new platform for developing ...

Nitrogen fixation in ambient conditions

November 12, 2018

Abundant in the atmosphere, nitrogen is rarely used in the industrial production of chemicals. The most important process using nitrogen is the synthesis of ammonia used for the preparation of agricultural fertilizers.

New catalyst turns pollutant into fuel

November 12, 2018

Rather than allow power plants and industry to toss carbon dioxide into the atmosphere, incoming Rice University assistant professor Haotian Wang has a plan to convert the greenhouse gas into useful products in a green way.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.